Exercise An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
Spruit et al. · American Journal of Respiratory and Critical Care Medicine
Key finding Pulmonary rehabilitation improves exercise capacity and quality of life in chronic lung disease.
The landmark joint statement establishing pulmonary rehabilitation as a core intervention for chronic lung disease, including bronchiectasis. Covers exercise training, education, and behaviour change.
Read paper ↗
Exercise Exercise training for bronchiectasis
Lee et al. · Cochrane Database of Systematic Reviews
Key finding Exercise training significantly improves exercise capacity and quality of life in BX — with no serious adverse events.
Cochrane review of exercise training in bronchiectasis. Found meaningful improvements in exercise capacity and health-related quality of life. No serious adverse events reported.
Read paper ↗
Airway Clearance Airway clearance techniques for bronchiectasis
McDonnell et al. · Cochrane Database of Systematic Reviews
Key finding ACT improves QoL and reduces sputum — but no single technique works best for everyone.
Systematic review of airway clearance techniques (ACT) in bronchiectasis. Finds ACT improves quality of life and reduces sputum burden. No single technique proven superior for all patients.
Read paper ↗
Treatment European Respiratory Society guidelines for the management of adult bronchiectasis
Chalmers et al. · European Respiratory Journal
Key finding Updated ERS guidelines recommend exercise and ACT as core management — antibiotics only when clearly indicated.
The most current ERS clinical guidelines for bronchiectasis management. Covers diagnosis, airway clearance, antibiotic use, mucoactive therapy, and exercise. Essential reference.
Read paper ↗
Epidemiology Prevalence of bronchiectasis in adults: a meta-analysis
Ni et al. · BMC Public Health
Key finding Global adult prevalence estimated at ~680 per 100,000 — higher than most clinicians realise.
First quantitative global synthesis of BX prevalence. Estimated at 680 per 100,000 adults — considerably higher than previously assumed, and likely an underestimate.
Read paper ↗
Mental Health Fatigue in patients with non-cystic fibrosis bronchiectasis
Aksamit et al. · Chest
Key finding Fatigue in BX is severe, underreported, and not fully explained by lung function alone.
Documents the significant burden of fatigue in non-CF bronchiectasis. Found fatigue is associated with worse quality of life independent of lung function — meaning it's not simply explained by airway obstruction.
Read paper ↗
Exacerbations Defining Exacerbations in Non-Cystic Fibrosis Bronchiectasis
Finch et al. · Chest
Key finding Earlier treatment of exacerbations leads to faster recovery and less cumulative damage.
Reviews the definition, recognition, and impact of exacerbations in non-CF bronchiectasis. Highlights that early treatment of exacerbations is associated with better outcomes.
Read paper ↗
Diagnosis Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013
Quint et al. · European Respiratory Journal
Key finding BX prevalence rose 40% in a decade — largely due to improved detection, not true incidence increase.
Large UK population study showing a 40% increase in BX prevalence over 10 years. Demonstrates significant diagnostic delay and underdiagnosis, particularly in primary care.
Read paper ↗